Ophthalmology
Volume 117, Issue 9 , Pages 1674-1683 , September 2010

Predicting the Onset of Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study

  • Robert N. Weinreb, MD

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
    • Corresponding Author InformationCorrespondence: Robert N. Weinreb, MD, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946
  • ,
  • Linda M. Zangwill, PhD

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
  • ,
  • Sonia Jain, PhD

      Affiliations

    • Family and Preventive Medicine, University of California-San Diego, La Jolla, California
  • ,
  • Lida M. Becerra, MS

      Affiliations

    • Family and Preventive Medicine, University of California-San Diego, La Jolla, California
  • ,
  • Keri Dirkes, MPH

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
  • ,
  • Jody R. Piltz-Seymour, MD

      Affiliations

    • University of Pennsylvania Health Systems, Bristol, Pennsylvania
  • ,
  • George A. Cioffi, MD

      Affiliations

    • Ophthal-Discoveries in Sight, Devers Eye Institute, Portland, Oregon
  • ,
  • Gary L. Trick, PhD

      Affiliations

    • Ophthalmology, Henry Ford Health System, Detroit, Michigan
  • ,
  • Anne L. Coleman, MD, PhD

      Affiliations

    • Jules Stein Institute-UCLA, Los Angeles, California
  • ,
  • James D. Brandt, MD

      Affiliations

    • University of California-Davis Eye Center, Sacramento, California
  • ,
  • Jefferey M. Liebmann, MD

      Affiliations

    • Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • ,
  • Mae O. Gordon, PhD

      Affiliations

    • Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri
  • ,
  • Michael A. Kass, MD

      Affiliations

    • Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri
  • ,
  • OHTS CSLO Ancillary Study Group

Received 13 November 2009 ,Revised 15 March 2010 ,Accepted 17 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Manuscript no. 2009-1585.

 Financial Disclosure(s): The authors have made the following disclosures.

 R.N. Weinreb - Support - Heidelberg Engineering, GmbH.

 L.M. Zangwill - Support - Heidelberg Engineering, Heidelberg, Germany; Carl Zeiss Meditec Inc, Dublin, CA.

 J. Piltz - Support - Seymour, Pfizer, Inc., Alcon Laboratories, Inc., Allergan, Inc., Merck.

 G.A. Cioffi - Consultant - Allergan, Inc., Pfizer Inc, C.

 G.L. Trick - Consultant - Allergan, Inc.

 A.L. Coleman - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.

 J.D. Brandt - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.; Lecturer - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.

 J.M. Liebmann - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Optovue, Inc., Heidelberg Engineering, GmbH, Pfizer, Inc., Topcon Medical Systems, Inc., Diopsys, Inc.; Support - Carl Zeiss Meditec, Inc.; Diopsys, Inc., Heidelberg Engineering, GmbH, Optovue, Inc., Pfizer, Inc., Topcon Medical Systems, Inc.

 M.A. Kass – Consultant – Pfizer, Inc.

 Supported by NIH/NEI grants, EY11158 (RNW), (EY09341, EY09307 [MOG, MAK]), Horncrest Foundation awards, NIH Vision Core Grant P30 EY02687, Merck Research Laboratories, Pfizer Inc, White House Station, New Jersey.

PII: S0161-6420(10)00323-4

doi: 10.1016/j.ophtha.2010.03.044

Ophthalmology
Volume 117, Issue 9 , Pages 1674-1683 , September 2010